Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,2-distearin Sn-3-phosphorylcholine
2. 1,2-distearoyllecithin
3. 1,2-distearoyllecithin, (+-)-isomer
4. 1,2-distearoyllecithin, (r)-isomer
5. 1,2-distearoyllecithin, (s)-isomer
6. 1,2-distearoylphosphatidylcholine
7. 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxooctadecyl)oxy)-3,5,9-trioxa-4-phosphahepta Cosan-1-aminium Hydroxide, Inner Salt, 4-oxide
8. Distearoyl Phosphatidylcholine
9. Distearoyl-sn-glycero-3-phosphocholine
10. Distearoylglycerophosphocholine
11. Distearoylphosphatidylcholine
12. Distearoylphosphatidylcholine, Dl-
13. Dl-dspc
14. Dspc R-isomer
15. L-distearoyllecithin
16. L-dspc
1. 816-94-4
2. Dspc
3. Distearoyl Phosphatidylcholine
4. (r)-2,3-bis(stearoyloxy)propyl (2-(trimethylammonio)ethyl) Phosphate
5. Pc(18:0/18:0)
6. 1,2-distearoyl-sn-3-phosphacholine
7. 1,2-dioctadecanoyl-sn-glycero-3-phosphocholine
8. 1,2-distearoyl-sn-glycero-3-phosphorylcholine
9. 3-sn-phosphatidylcholine
10. Di-stearoyl-phosphatidylcholine
11. 043ipi2m0k
12. Phosphatidylcholine(18:0/18:0)
13. Gpcho(18:0/18:0)
14. [(2r)-2,3-di(octadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl Phosphate
15. Nsc-725285
16. Unii-043ipi2m0k
17. (r)-2,3-bis(stearoyloxy)propyl [2-(trimethylammonio)ethyl] Phosphate
18. Einecs 212-440-2
19. L-beta,gamma,disteroyl-alpha-lecithin
20. Mfcd00036905
21. L-alpha-phosphatidylcholine, Distearoyl
22. 1,2-distearoyl-sn-glycerophosphocholine
23. Dspc R-isomer
24. L-distearoyllecithin
25. Schembl24563
26. 1,2-dspc
27. Chebi:83718
28. 18:0 Pc (dspc)
29. Dtxsid20231218
30. Bcp11135
31. Lmgp01010006
32. Nsc725285
33. Distearoyl-l-.alpha.-lecithin
34. Akos016012934
35. Distearoyl Glycerophosphocholine
36. Distearoyl-sn-glycero-3-phosphocholine
37. Cs-w020933
38. Gs-6169
39. Hy-w040193
40. Nsc 725285
41. (r)-(7-lauroyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphaheptacosyl)trimethylammonium 4-oxide
42. L-alpha-phosphatidyl Choline, Distearoyl
43. 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxooctadecyl)oxy)-3,5,9-trioxa-4-phosphaheptacosan-1-aminium Hydroxide, Inner Salt, 4-oxide, (r)-
44. Bp-25623
45. Gpc(18:0/18:0)
46. D3926
47. Pc (18:0)2
48. 1,2-distearin Sn-3-phosphorylcholine
49. Distearoyl Glycerophosphocholine [inci]
50. Pc 18:0/18:0
51. 1,2-distearoyl-sn-glycero-3-phosphatidylcholine
52. A864508
53. 1,2-diastearoyl-sn-glycero-3-phosphocholine
54. 1,2-distearoyl-sn-glycero-3-phosphocholine, >=99%
55. Q27157143
56. 1,2-distearoyl-sn-glycero-3-phosphocholine [ii]
57. 1,2-distearoyl-sn-glycero-3-phosphocholine (dspc)
58. 1,2-distearoyl-sn-glycero-3-phosphocholine, >=99% (tlc)
59. (2r)-2,3-bis(octadecanoyloxy)propyl 2-(trimethylammonio)ethyl Phosphate
60. (2r)-2,3-bis(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl Phosphate
61. 18:0 Pc (dspc), 1,2-distearoyl-sn-glycero-3-phosphocholine, Powder
62. (2-{[(2r)-2,3-bis(octadecanoyloxy)propyl Phosphono]oxy}ethyl)trimethylazanium
63. 3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxooctadecyl)oxy)-, Hydroxide, Inner Salt, 4-oxide, (r)-
64. 3,5,9-trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxooctadecyl)oxy)-, Inner Salt, 4-oxide, (7r)-
1. Dioctadecanoyllecithin
2. 18603-43-5
3. 1,2-distearoyl-rac-glycero-3-phosphocholine
4. 2,3-di(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl Phosphate
Molecular Weight | 790.1 g/mol |
---|---|
Molecular Formula | C44H88NO8P |
XLogP3 | 15.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 44 |
Exact Mass | 789.62475576 g/mol |
Monoisotopic Mass | 789.62475576 g/mol |
Topological Polar Surface Area | 111 Ų |
Heavy Atom Count | 54 |
Formal Charge | 0 |
Complexity | 888 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25436
Submission : 2011-10-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19642
Submission : 2006-07-31
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40253
Submission : 2024-08-08
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14970
Submission : 2000-07-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40045
Submission : 2024-06-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5916
Submission : 1985-06-17
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21738
Submission : 2008-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25436
Submission : 2011-10-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21738
Submission : 2008-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5916
Submission : 1985-06-17
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40045
Submission : 2024-06-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14970
Submission : 2000-07-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19642
Submission : 2006-07-31
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40253
Submission : 2024-08-08
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
ABOUT THIS PAGE
51
PharmaCompass offers a list of DSPC API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right DSPC manufacturer or DSPC supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred DSPC manufacturer or DSPC supplier.
PharmaCompass also assists you with knowing the DSPC API Price utilized in the formulation of products. DSPC API Price is not always fixed or binding as the DSPC Price is obtained through a variety of data sources. The DSPC Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 043IPI2M0K manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 043IPI2M0K, including repackagers and relabelers. The FDA regulates 043IPI2M0K manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 043IPI2M0K API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 043IPI2M0K supplier is an individual or a company that provides 043IPI2M0K active pharmaceutical ingredient (API) or 043IPI2M0K finished formulations upon request. The 043IPI2M0K suppliers may include 043IPI2M0K API manufacturers, exporters, distributors and traders.
click here to find a list of 043IPI2M0K suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 043IPI2M0K DMF (Drug Master File) is a document detailing the whole manufacturing process of 043IPI2M0K active pharmaceutical ingredient (API) in detail. Different forms of 043IPI2M0K DMFs exist exist since differing nations have different regulations, such as 043IPI2M0K USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 043IPI2M0K DMF submitted to regulatory agencies in the US is known as a USDMF. 043IPI2M0K USDMF includes data on 043IPI2M0K's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 043IPI2M0K USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 043IPI2M0K suppliers with USDMF on PharmaCompass.
043IPI2M0K Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 043IPI2M0K GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 043IPI2M0K GMP manufacturer or 043IPI2M0K GMP API supplier for your needs.
A 043IPI2M0K CoA (Certificate of Analysis) is a formal document that attests to 043IPI2M0K's compliance with 043IPI2M0K specifications and serves as a tool for batch-level quality control.
043IPI2M0K CoA mostly includes findings from lab analyses of a specific batch. For each 043IPI2M0K CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
043IPI2M0K may be tested according to a variety of international standards, such as European Pharmacopoeia (043IPI2M0K EP), 043IPI2M0K JP (Japanese Pharmacopeia) and the US Pharmacopoeia (043IPI2M0K USP).